ResearcherUniversity of GenoaActive in the last 2 years
Stefania Sciallero
Matched on ORCID iD 0000-0002-1325-1701; OpenAlex author ID A5006768444. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper
Papers 7
- Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. Co-author DOI 10.1016/j.ejca.2024.114226↗
- Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. Co-author DOI 10.1200/po.22.00145↗
- Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers14184447↗
- Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply. Last author DOI 10.1056/nejmc1911185↗
- Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development. Co-author DOI 10.1371/journal.pone.0189123↗
- Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Co-author DOI 10.1007/s10689-011-9483-5↗
- CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. Co-author DOI 10.1136/jmedgenet-2011-100281↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William Bruno · 6 shared papers, 2012–2024 · strength 0.49
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Paper Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. DOI 10.1200/po.22.00145↗
- Lorenza Pastorino · 6 shared papers, 2012–2024 · strength 0.49
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Paper Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. DOI 10.1200/po.22.00145↗
- Paola Ghiorzo · 6 shared papers, 2012–2024 · strength 0.49
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Paper Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. DOI 10.1200/po.22.00145↗
- Alberto Puccini · 3 shared papers, 2019–2024 · strength 0.43
- Paper Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply. DOI 10.1056/nejmc1911185↗
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Bruna Dalmasso · 2 shared papers, 2022–2024 · strength 0.27
- Paper Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patien… DOI 10.1016/j.ejca.2024.114226↗
- Paper Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of I… DOI 10.3390/cancers14184447↗
- Marina Macchini · 1 shared paper, 2024 · strength 0.15
- Laura Cortesi · 1 shared paper, 2024 · strength 0.15
- Catia Carconi · 1 shared paper, 2024 · strength 0.15
- Giulia Orsi · 1 shared paper, 2024 · strength 0.15
- Guido Giordano · 1 shared paper, 2024 · strength 0.15
- Matteo Landriscina · 1 shared paper, 2024 · strength 0.15
- Lívia Archibugi · 1 shared paper, 2024 · strength 0.15
- Marta Chiaravalli · 1 shared paper, 2024 · strength 0.15
- Gabriele Capurso · 1 shared paper, 2024 · strength 0.15
- Lisa Salvatore · 1 shared paper, 2024 · strength 0.15
- Giampaolo Tortora · 1 shared paper, 2024 · strength 0.15
- Massimo Falconi · 1 shared paper, 2024 · strength 0.15
- Michele Reni · 1 shared paper, 2024 · strength 0.15
- Stefano Cascinu · 1 shared paper, 2024 · strength 0.15
- Giovanna Bianchi‐Scarrà · 3 shared papers, 2012–2017 · strength 0.12
- Paper Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development. DOI 10.1371/journal.pone.0189123↗
- Paper Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. DOI 10.1007/s10689-011-9483-5↗
- Paper CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. DOI 10.1136/jmedgenet-2011-100281↗
- Esteban Astiazarán-Symonds · 1 shared paper, 2022 · strength 0.11
- Nelleke A. Gruis · 1 shared paper, 2022 · strength 0.11
- Alisa M. Goldstein · 1 shared paper, 2022 · strength 0.11
- Joshua Neil Sampson · 1 shared paper, 2022 · strength 0.11
- Xiaohong Rose Yang · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.